Sequent Medical, Inc., an Aliso Viejo, CA-based company dedicated to the development of innovative devices to advance the endovascular treatment of neurovascular disease conditions, has closed a $15.6m Series B venture capital financing.
The round was led by Domain Associates, with participation from existing investors Versant Ventures and US Venture Partners.
In conjunction with the funding, Nimesh Shah of Domain will join the company’s board of directors.
As stated by Tom Wilder, who joined in February 2010 as President and Chief Executive Officer, the company “will utilize these funds to continue our development programs, including the introduction of our initial WEB(TM) product line”.
The WEB(TM) aneurysm embolization system provides a new treatment alternative for cerebral aneurysms, especially those prone to a high rate of recurrence and treatment.